Treatment of psychiatric and neurocognitive sequelae of COVID-19 disease in adolescents and young adults

Not Applicable

Recruiting

• Conditions: F06.8; U09.9; Other specified mental disorders due to brain damage and dysfunction and to physical disease; Post COVID-19 condition, unspecified

• Registration Number: DRKS00032428
• Lead Sponsor: Klinikum Karlsbad Langensteinbach

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Diagnosis of psychiatric or cognitive disorders following an COVID-19 infection (Post COVID syndrome)

Exclusion Criteria

- no evidence of past infection with SARS-CoV-2
- age under 15 or above 21 years

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determination before and after therapy of:<br>BDI-FS - Beck Depression Inventory Fast Screen<br>BSCL - Brief Symptom Check List<br>FSMC - Fatigue Skala for Motoric and Cognition<br>PEM -DSQ - Postexertional Malaise DePaul Symptom Questionnaire<br>MADRS - Montgomery Asberg Depression Rating Scale<br>COGBAT - Cognitive Basic Assesment<br>MKS - Marburg Competence Scale<br>ILK - Inventory on Quality of Life in Children and Adolescents